Mayne Pharma Group
Update in progressMYX.AX (ASX)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryMedical Distribution
Mayne Pharma Group Limited is a specialty pharmaceutical company focused on commercializing women’s health and dermatology products in Australia, New Zealand, the United States, Canada, Europe, Asia, and other regions. It operates in three segments—Women’s Health, Dermatology, and International—and provides oral drug delivery systems plus contract development and manufacturing for third parties. It also distributes dermatology, women’s health, and infectious disease products. Formerly Halcygen Pharmaceuticals Limited, it changed its name in 2010. The company was incorporated in 2005 and is based in Salisbury South, Australia.
Company score
- Sentiment
- 0.06
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.00
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- -0.02
- Governance
- 0.01
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.00
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.03
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Loading section